215 related articles for article (PubMed ID: 38203311)
1. An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer.
Su Y; Wang F; Lei Z; Li J; Ma M; Yan Y; Zhang W; Chen X; Xu B; Hu T
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203311
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract][Full Text] [Related]
3. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract][Full Text] [Related]
6. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
[TBL] [Abstract][Full Text] [Related]
7. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
Zheng K; Hai Y; Chen H; Zhang Y; Hu X; Ni K
J Transl Med; 2024 Apr; 22(1):365. PubMed ID: 38632658
[TBL] [Abstract][Full Text] [Related]
8. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
11. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
12. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer.
Liu X; Shi J; Tian L; Xiao B; Zhang K; Zhu Y; Zhang Y; Jiang K; Zhu Y; Yuan H
BMC Cancer; 2023 Dec; 23(1):1229. PubMed ID: 38097951
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer.
Lu S; Hua J; Liu J; Wei M; Liang C; Meng Q; Zhang B; Yu X; Wang W; Xu J
BMC Cancer; 2022 Jul; 22(1):804. PubMed ID: 35864471
[TBL] [Abstract][Full Text] [Related]
16. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract][Full Text] [Related]
17. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes.
Cui Y; Yuan Q; Chen J; Jiang J; Guan H; Zhu R; Li N; Liu W; Wang C
Front Endocrinol (Lausanne); 2023; 14():1127441. PubMed ID: 37223030
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
19. Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature.
Wu Y; Shang J; Ruan Q; Tan X
Sci Rep; 2023 Oct; 13(1):17577. PubMed ID: 37845218
[TBL] [Abstract][Full Text] [Related]
20. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
